Drug intelligence / Profile preview

Aceclofenac + Esomeprazole

Development stage
Unknown
Lead developer
Almirall
Modality
Small Molecules
Administration
Oral
01

Overview

Aceclofenac + esomeprazole is a fixed-dose combination of two active pharmaceutical ingredients: - **Aceclofenac** is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. It is primarily used to treat conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute pain[5][8]. - **Esomeprazole** is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly binding to the H+, K+-ATPase enzyme in gastric parietal cells. This action reduces both basal and stimulated acid production[6]. The combination aims to provide effective pain relief while minimizing gastrointestinal side effects commonly associated with NSAIDs by including a PPI for gastroprotection[3][8]. The formulation improves patient convenience and adherence by combining both agents into one dosage form.

Brand names
Aclon-E
Other names
Aceclofenac/Esomeprazole Dong WhaAclon EDW-6008DW6008DW 6008
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Aceclofenac + Esomeprazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aceclofenac + Esomeprazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call